Literature DB >> 19125127

EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome.

Glenn E Palomaki1, Monica R McClain, Stephanie Melillo, Heather L Hampel, Stephen N Thibodeau.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19125127      PMCID： PMC2743613          DOI： 10.1097/GIM.0b013e31818fa2db

Source DB:  PubMed          Journal:  Genet Med        ISSN： 1098-3600            Impact factor:   8.822


× No keyword cloud information.
  132 in total

1.  Predictive genetic testing for hereditary non-polyposis colorectal cancer: uptake and long-term satisfaction.

Authors:  K Aktan-Collan; J P Mecklin; H Järvinen; M Nyström-Lahti; P Peltomäki; I Söderling; A Uutela; A de la Chapelle; H Kääriäinen
Journal:  Int J Cancer       Date:  2000-01-20       Impact factor: 7.396

2.  Impact of genetic counseling and DNA testing on individuals with colorectal cancer with a positive family history: a population-based study.

Authors:  Starlene Loader; Cleveland Shields; Peter T Rowley
Journal:  Genet Test       Date:  2005

Review 3.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.

Authors:  C R Boland; S N Thibodeau; S R Hamilton; D Sidransky; J R Eshleman; R W Burt; S J Meltzer; M A Rodriguez-Bigas; R Fodde; G N Ranzani; S Srivastava
Journal:  Cancer Res       Date:  1998-11-15       Impact factor: 12.701

4.  BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum.

Authors:  T Kambara; L A Simms; V L J Whitehall; K J Spring; C V A Wynter; M D Walsh; M A Barker; S Arnold; A McGivern; N Matsubara; N Tanaka; T Higuchi; J Young; J R Jass; B A Leggett
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

5.  Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer.

Authors:  M B Loughrey; P M Waring; A Tan; M Trivett; S Kovalenko; V Beshay; M-A Young; G McArthur; A Boussioutas; A Dobrovic
Journal:  Fam Cancer       Date:  2007-04-24       Impact factor: 2.375

6.  Penetrance and expressivity of MSH6 germline mutations in seven kindreds not ascertained by family history.

Authors:  Barbara M Buttin; Matthew A Powell; David G Mutch; Sheri A Babb; Phyllis C Huettner; Tina Bocker Edmonston; Thomas J Herzog; Janet S Rader; Randall K Gibb; Alison J Whelan; Paul J Goodfellow
Journal:  Am J Hum Genet       Date:  2004-04-19       Impact factor: 11.025

7.  A randomised prospective trial comparing laparoscopic and abdominal hysterectomy.

Authors:  J H Olsson; M Ellstrom; M Hahlin
Journal:  Br J Obstet Gynaecol       Date:  1996-04

8.  Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome).

Authors:  Yvonne M C Hendriks; Shantie Jagmohan-Changur; Heleen M van der Klift; Hans Morreau; Marjo van Puijenbroek; Carli Tops; Theo van Os; Anja Wagner; Margreet G F M Ausems; Encarna Gomez; Martijn H Breuning; Annette H J T Bröcker-Vriends; Hans F A Vasen; Juul Th Wijnen
Journal:  Gastroenterology       Date:  2006-02       Impact factor: 22.682

9.  Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis.

Authors:  H F Vasen; J T Wijnen; F H Menko; J H Kleibeuker; B G Taal; G Griffioen; F M Nagengast; E H Meijers-Heijboer; L Bertario; L Varesco; M L Bisgaard; J Mohr; R Fodde; P M Khan
Journal:  Gastroenterology       Date:  1996-04       Impact factor: 22.682

10.  Patients with an unexplained microsatellite instable tumour have a low risk of familial cancer.

Authors:  L I H Overbeek; C M Kets; K M Hebeda; D Bodmer; E van der Looij; R Willems; M Goossens; N Arts; H G Brunner; J H J M van Krieken; N Hoogerbrugge; M J L Ligtenberg
Journal:  Br J Cancer       Date:  2007-04-24       Impact factor: 7.640
View more
  183 in total

1.  How comparative effectiveness research can help advance 'personalized medicine' in cancer treatment.

Authors:  Scott D Ramsey; David Veenstra; Sean R Tunis; Louis Garrison; John J Crowley; Laurence H Baker
Journal:  Health Aff (Millwood)       Date:  2011-12       Impact factor: 6.301

Review 2.  Genetics for the general internist.

Authors:  Christina M Laukaitis
Journal:  Am J Med       Date:  2011-11-11       Impact factor: 4.965

3.  Identification of individuals at risk for Lynch syndrome using targeted evaluations and genetic testing: National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Colorectal Cancer joint practice guideline.

Authors:  Scott M Weissman; Randall Burt; James Church; Steve Erdman; Heather Hampel; Spring Holter; Kory Jasperson; Matt F Kalady; Joy Larsen Haidle; Henry T Lynch; Selvi Palaniappan; Paul E Wise; Leigha Senter
Journal:  J Genet Couns       Date:  2011-12-14       Impact factor: 2.537

Review 4.  Clinical implications of mismatch repair deficiency in prostate cancer.

Authors:  Ramy Sedhom; Emmanuel S Antonarakis
Journal:  Future Oncol       Date:  2019-06-25       Impact factor: 3.404

5.  Making sense of missense in Lynch syndrome: the clinical perspective.

Authors:  Henry T Lynch; Thomas Jascur; Stephen Lanspa; C Richard Boland
Journal:  Cancer Prev Res (Phila)       Date:  2010-10-26

Review 6.  Challenges of translating genetic tests into clinical and public health practice.

Authors:  Wolf H Rogowski; Scott D Grosse; Muin J Khoury
Journal:  Nat Rev Genet       Date:  2009-07       Impact factor: 53.242

Review 7.  History, genetics, and strategies for cancer prevention in Lynch syndrome.

Authors:  Fay Kastrinos; Elena M Stoffel
Journal:  Clin Gastroenterol Hepatol       Date:  2013-07-23       Impact factor: 11.382

8.  Lynch Syndrome in high risk Ashkenazi Jews in Israel.

Authors:  Yael Goldberg; Inbal Kedar; Revital Kariiv; Naama Halpern; Morasha Plesser; Ayala Hubert; Luna Kaduri; Michal Sagi; Israela Lerer; Dvorah Abeliovich; Tamar Hamburger; Aviram Nissan; Hanoch Goldshmidt; Irit Solar; Ravit Geva; Hana Strul; Guy Rosner; Hagit Baris; Zohar Levi; Tamar Peretz
Journal:  Fam Cancer       Date:  2014-03       Impact factor: 2.375

9.  Evaluation of clinical criteria for the identification of Lynch syndrome among unselected patients with endometrial cancer.

Authors:  Amanda S Bruegl; Bojana Djordjevic; Brittany Batte; Molly Daniels; Bryan Fellman; Diana Urbauer; Rajyalakshmi Luthra; Charlotte Sun; Karen H Lu; Russell R Broaddus
Journal:  Cancer Prev Res (Phila)       Date:  2014-04-25

10.  Clinical Challenges Associated with Universal Screening for Lynch Syndrome-Associated Endometrial Cancer.

Authors:  Amanda S Bruegl; Kari L Ring; Molly Daniels; Bryan M Fellman; Diana L Urbauer; Russell R Broaddus
Journal:  Cancer Prev Res (Phila)       Date:  2016-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.